U.K. docs: Almost half of J&J hip devices fail after 6 years

A hip replacement made by Johnson & Johnson ($JNJ)'s DePuy unit fails in the UK as often as 49 percent of the time, or four times what the company cited in recalling the device last year, a British orthopedists' group said. Report

Suggested Articles

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.

A patent decision in Delaware clears the way for multiple generic companies to launch their Tecfidera copycats—and target its $3.3B in U.S. sales.

Sanofi and GlaxoSmithKline signed a deal with the EU to supply up to 300 million doses of their recombinant protein-based COVID-19 vaccine.